Montelukast sodium (Macleods Pharmaceuticals Limited)
Welcome to the PulseAid listing for the Montelukast sodium drug offered from Macleods Pharmaceuticals Limited. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Macleods Pharmaceuticals Limited |
NON-PROPRIETARY NAME: | Montelukast sodium |
SUBSTANCE NAME: | MONTELUKAST |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-04-01 |
END MARKETING DATE: | 0000-00-00 |
Montelukast sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Montelukast sodium from Macleods Pharmaceuticals Limited |
LABELER NAME: | Macleods Pharmaceuticals Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2014-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 33342-110_3d5ccdc5-b890-44b3-9104-baa689e6f33c |
PRODUCT NDC: | 33342-110 |
APPLICATION NUMBER: | ANDA203582 |
Other MONTELUKAST Pharmaceutical Manufacturers / Labelers: